APA (7th ed.) Citation

Koda, M., Imagama, S., Nakashima, H., Ito, S., Segi, N., Ouchida, J., . . . Nakamae, T. (2024). Correction: Safety and feasibility of intravenous administration of a single dose of allogenic-Muse cells to treat human cervical traumatic spinal cord injury: a clinical trial. Stem Cell Research & Therapy, 15(1), 1. https://doi.org/10.1186/s13287-024-04044-0

Chicago Style (17th ed.) Citation

Koda, Masao, et al. "Correction: Safety and Feasibility of Intravenous Administration of a Single Dose of Allogenic-Muse Cells to Treat Human Cervical Traumatic Spinal Cord Injury: A Clinical Trial." Stem Cell Research & Therapy 15, no. 1 (2024): 1. https://doi.org/10.1186/s13287-024-04044-0.

MLA (9th ed.) Citation

Koda, Masao, et al. "Correction: Safety and Feasibility of Intravenous Administration of a Single Dose of Allogenic-Muse Cells to Treat Human Cervical Traumatic Spinal Cord Injury: A Clinical Trial." Stem Cell Research & Therapy, vol. 15, no. 1, 2024, p. 1, https://doi.org/10.1186/s13287-024-04044-0.